Alcohol sclerotherapy for pelvic pain and quality of life in ovarian endometrioma
Official title: Effect of US-guided Alcohol Sclerotherapy for Endometriomas on Pelvic Pain and Quality of Life
Run by Hospital Universitari de Bellvitge · NCT06955221 · Data updated 2026-11-12
This trial will try ultrasound-guided alcohol sclerotherapy to see if it reduces pelvic pain and improves quality of life in women aged 18–45 with ovarian endometriomas compared with expectant management.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 288 (estimated) |
| Sponsor | Hospital Universitari de Bellvitge Academic / other |
| Locations | 26 sites (Palma de Mallorca, Balearic Islands and 25 other locations) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06955221 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–45 with ultrasound-suspected unilocular (or thin-septum) ovarian endometriomas 30–100 mm in size, CA125 ≤300 UI/mL and HE4 ≤70 pM, not pregnant and willing to give informed consent.
✕Probably not a fit
Patients with very small (<30 mm) or very large (>100 mm) cysts, ultrasound signs suggesting dermoid or high malignancy risk, those requiring surgical treatment for severe extra-ovarian disease, pregnant women, or those with prior ovarian/uterine cancer are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women meeting entry criteria are randomly assigned to receive ultrasound-guided aspiration with alcohol sclerotherapy or to expectant management, with outcomes compared at six months. Pain and quality of life are measured using standardized instruments including the EHP-5, and blood and urine samples are collected for biomarkers such as cortisol, IL-6, and hsCRP. The intervention is a minimally invasive outpatient procedure performed under ultrasound guidance, and the control arm receives routine monitoring without immediate intervention. The trial focuses on unilocular or thin-septum endometriomas sized 30–100 mm and excludes cases with suspicion of malignancy or indications for immediate surgery.
Why it matters
Potential benefit: If successful, the procedure could reduce pelvic pain and improve quality of life while avoiding or delaying surgery and preserving ovarian tissue.
How similar studies have gone: Smaller series and nonrandomized reports have shown symptom relief and cyst reduction after alcohol sclerotherapy, but high-quality randomized data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex * Age ≥18 and ≤45 years * Ultrasound suspicion of unilocular endometrioma or with a thin septum less than 3 mm * Size between 30-100 mm, persistent for at least 3-6 months since diagnosis * Ca125 marker \<300 UI/mL and HE4 \< 70 pM * Signed informed consent Exclusion Criteria: * Age \<18 or \>45 years * History of ovarian or uterine cancer * Endometrioma size \<30 mm or \>100 mm * Indication for surgical treatment of the endometrioma due to suspected severe extra-ovarian endometriosis or any other cause * Ultrasound suspicion of dermoid cysts, anechoic cysts, or cysts with high risk of malignancy * Ca125 \>300 UI/mL * HE4 \>70 pM * Pregnant women * Patients who do not wish to participate in the study or who are mentally incapacitated
Where it's running
-
Consorci Sanitari de l'Anoia
Igualada, Barcelona, Spain Recruiting -
Consorci Sanitari Integral
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Hospital de Viladecans
Viladecans, Barcelona, Spain Recruiting -
Hospital General Universitario Los Arcos del Mar Menor
San Javier, Murcia, Spain Recruiting -
Hospital del Mar
Barcelona, Spain Recruiting
Show 20 more locations
-
Hospital Universitario Ramón y Cajal
Madrid, Spain Recruiting -
Hospital Clínico San Carlos
Madrid, Spain Recruiting -
Hospital Universitario 12 de Octubre
Madrid, Spain Recruiting -
Hospital Recoletas Salud Campo Grande
Valladolid, Spain Recruiting -
Hospital Universitario Son Espases
Palma de Mallorca, Balearic Islands, Spain Not yet recruiting -
Hospital Universitario Germans Trias i Pujol
Badalona, Barcelona, Spain Not yet recruiting -
Hospital San Juan de Dios de Martorell
Martorell, Barcelona, Spain Not yet recruiting -
Consorci Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain Not yet recruiting -
Parc Sanitari Sant Joan de Deu
Sant Boi de Llobregat, Barcelona, Spain Not yet recruiting -
Hospital Universitario San Pedro
Logroño, La Rioja, Spain Not yet recruiting -
Hospital de la Vega Lorenzo Guirao
Cieza, Murcia, Spain Not yet recruiting -
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain Not yet recruiting -
Hospital Universitari Sant Joan de Reus
Reus, Tarragona, Spain Not yet recruiting -
Clínica Sanabria
Granada, Spain Not yet recruiting -
Hospital Universitario de Jaén
Jaén, Spain Not yet recruiting -
Hospital Universitario Arnau de Vilanova
Lleida, Spain Not yet recruiting -
Hospital Universitario Joan XXIII
Tarragona, Spain Not yet recruiting -
Consorcio Hospital General Universitario de València
Valencia, Spain Not yet recruiting -
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Spain Not yet recruiting -
Hospital Universitario de Álava - Txagorritxu
Vitoria-Gasteiz, Álava, Spain Not yet recruiting
Study contacts
- Principal investigator: Amparo Garcia-Tejedor, MDPhD — Hospital Universitari de Bellvitge
- Study coordinator: Amparo Garcia-Tejedor, MDPhD
- Email: agarciat@bellvitgehospital.cat
- Phone: 34 + 932607695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized Exercise Recommendations for Chronic Pelvic Pain
This study tests if an AI-powered, personalized exercise plan can help people with chronic pelvic pain see if tailored workouts work better than standard guidance.
-
Samphire Guided Care for Wellbeing at Work
This study tests a 12-week digital program with at-home neuromodulation to see if it helps women with menstrual or perimenopausal symptoms feel better at work and in daily life.
-
High-intensity interval training to reduce menstrual pain and improve menstrual health in women with primary dysmenorrhea
This 12-week program will try supervised online high-intensity interval training plus a menstrual health workshop to see if it reduces menstrual pain and improves quality of life for women aged 18–40 with primary dysmenorrhea.
-
PEMM for women with chronic low back pain and urinary leakage
This study will try pelvic external myofascial mobilization (PEMM) with core exercises to see if it lowers pain, reduces disability, and improves urinary leakage and mental health in women with chronic low back pain and urinary incontinence.
-
Electroacupuncture for pelvic pain in women with suspected endometriosis
This study tests whether a series of electroacupuncture sessions can reduce pelvic pain in women awaiting diagnostic laparoscopy for suspected endometriosis.
-
Franco-European Institute of Endometriosis long-term outcomes cohort
This cohort will follow women with confirmed pelvic endometriosis to see if different medical and surgical treatments lead to better long-term symptoms, quality of life, recurrence rates, and fertility outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.